Shortcuts 2021 2020

2021

  • Empowered Patient Podcast
    Optimizing Autologous Cell Therapy to Treat Cardiovascular Disease with Dr. Peter Altman Read More

  • UW Health
    UW Health Treats First Patient in U.S. with Investigational Cell Therapy for Heart Disease Read More

  • Greenbay CBS
    Neenah musician, educator pursues dream after being first in the world to undergo ‘Investigational Cell Therapy’ Read More

  • WBay.com
    Neenah man gets new lease on life after trial heart procedure Read More

  • Henry Ford Health System
    Henry Ford Health System Studies Novel Cell Therapy Aimed at Improving Heart Failure Symptoms Read More

  • Cell & Gene
    Inside BioCardia's CardiAMP Cell Therapy Read More

2020

  • BioTuesdays
    BioCardia developing autologous and allogenic cardiovascular cell therapies Read More

  • Pharmaceutical Technology
    BioCardia’s novel CardiAMP stem cell therapy closer to approval in heart failure Read More

  • The Big Biz show
    The Big Biz Show interviews BioCardia CEO, Peter Altman Read More

News

01 Dec

Empowered Patient Podcast

Optimizing Autologous Cell Therapy to Treat Cardiovascular Disease with Dr. Peter Altman
Read More
29 Oct

UW Health

UW Health Treats First Patient in U.S. with Investigational Cell Therapy for Heart Disease
Read More
29 Oct

Greenbay CBS

Neenah musician, educator pursues dream after being first in the world to undergo ‘Investigational Cell Therapy’
Read More
29 Oct

WBay.com

Neenah man gets new lease on life after trial heart procedure
Read More
04 Mar

Henry Ford Health System

Henry Ford Health System Studies Novel Cell Therapy Aimed at Improving Heart Failure Symptoms
Read More
08 Feb

Cell & Gene

Inside BioCardia's CardiAMP Cell Therapy
Read More

press releases

03 Oct
2022 BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Trial Two-Year Data at HFSA Annual Meeting
14 Sep
2022 CardiAMP Cell Therapy Heart Failure Trial Two Year Roll-In Cohort Data to be Presented at Heart Failure Society of America Annual Meeting
09 Sep
2022 BioCardia Announces Participation at H.C. Wainwright Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)
08 Sep
2022 BioCardia to Participate in Cantor Fitzgerald’s Cell and Genetic Medicines Conference
31 Aug
2022 BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial
24 Aug
2022 BioCardia Enters Agreement with BlueRock Therapeutics to Provide Enabling Catheter Biotherapeutic Delivery Product Candidates for BlueRock’s Cell Therapy to Treat Heart Failure
Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.
CLINICAL TRIALS